Novo Nordisk
NVO
NVO
1,737 hedge funds and large institutions have $41.8B invested in Novo Nordisk in 2024 Q1 according to their latest regulatory filings, with 319 funds opening new positions, 726 increasing their positions, 481 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
14% more funds holding in top 10
Funds holding in top 10: 70 → 80 (+10)
0.15% more ownership
Funds ownership: 9.31% → 9.46% (+0.15%)
10% less call options, than puts
Call options by funds: $1.01B | Put options by funds: $1.13B
Holders
1,737
Holding in Top 10
80
Calls
$1.01B
Puts
$1.13B
Top Buyers
| 1 | +$634M | |
| 2 | +$405M | |
| 3 | +$221M | |
| 4 |
GAM
Groupama Asset Management
Paris,
France
|
+$172M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$148M |
Top Sellers
| 1 | -$1.18B | |
| 2 | -$393M | |
| 3 | -$222M | |
| 4 |
Jennison Associates
New York
|
-$185M |
| 5 |
SFM
Soros Fund Management
New York
|
-$97.2M |